«We are all excited about the potential of this new
approach to provide a new way of
vaccine delivery,» says Robert Langer, the David H. Koch Institute Professor at MIT and an author of the paper.
We are particularly interested in leverage our interdisciplinary expertise in polymer chemistry, nanomedicine, drug
delivery and immunobiology to innovate new
approaches to modulate the tumor microenvironment and enhance cellular immune responses to cancer
vaccines.